S erum concentrations of high-density (HDL-C) and lowdensity lipoprotein cholesterol (LDL-C), triglycerides (TG), and total cholesterol (TC) are heritable risk factors for cardiovascular disease. 1 Recent genome-wide association (GWA) studies have identified 95 common DNA sequence variants with moderate effect sizes associated with serum lipids, using samples from adult populations. Associated single nucleotide polymorphisms (SNPs) explain in aggregate 10 -12% of total variation or 20 -25% of heritable variation in lipid concentration levels in adults. [2] [3] [4] [5] Clinical Perspective on p 680
Lipid levels vary over age among young and adolescent children. HDL-C levels decrease notably after puberty onset in males and TG increase faster in males than in females during and after puberty. 6 -10 Changes in lipid concentrations during puberty have been related to sex hormone and hormone-binding protein levels. 11 Childhood serum lipid levels have also been shown to predict lipid measurements among adults. Therefore, lipid level measurements taken at a young age can be important in the early detection of lipoprotein disorders and increased coronary heart disease risk. 12, 13 However, the role of genes in these processes is unknown.
It is not known how lipid loci, identified using crosssectional samples of adult populations of European origin, are associated with lipids in young children and during puberty and how the association changes over age. In this study, we used previously identified lipid-associated loci and tested their effect on the concentrations of the serum lipids from early childhood to adulthood in the Cardiovascular Risk in Young Finns Study cohort. More specifically, we tested 3 hypotheses: (1) Are the previously identified lipid loci associated with lipids also in children and adolescents? (2) How much of the total variance in lipid levels can be explained by lipid-associated SNPs in different age groups? (3) Can the genetic risk score (GRS), based on currently known loci, be used to make more precise predictions of dyslipidemia among adults than using only childhood lipid measurement?
Methods

The Cardiovascular Risk in Young Finns Study
The Cardiovascular Risk in Young Finns Study is a follow-up study aiming to reveal cardiovascular risk factors and atherosclerosis precursors from Finnish children and adolescents. The study details and methods have been described elsewhere, 14 -16 but we review the main details here. The study started in 1980, when randomly chosen 3596 Finns, ages 3, 6, 9, 12, 15, and 18 years, participated in the first cross-sectional survey. Waves of follow-up with clinical measurements have been performed in 1983, 1986, 2001, and 2007 . During the latest follow-up, the participants were between 30 and 45 years of age (Figure 1) .
Serum lipid concentrations (HDL-C, LDL-C, TG, and TC) have been measured in each of these follow-ups, using standard methods in the laboratory of the Research and Development Unit of the Social Insurance Institution, Turku, Finland. In 1980, 1983, and 1986, serum TC and TG were measured, using a fully enzymatic method (Boehringer Mannheim, Mannheim, Germany). HDL-C was measured from the supernatant after precipitation of very low-density lipoprotein cholesterol and LDL-C with dextran sulfate 500 000 (Pharmacia, Uppsala, Sweden). In 2001 and 2007, TC levels were measured by the enzymatic cholesterol esterase (Cholesterol reagent, Olympus, O'Callaghans Mills, Co. Clare, Ireland). The same reagent was used for estimating HDL-C levels after precipitation of LDL-C and very low-density lipoprotein cholesterol with dextran sulfateMg 2ϩ . Triglycerides were assayed by using the enzymatic glycerol kinase (Triglyceride reagent, Olympus). The concentration of LDL-C was calculated by using the Friedewald formula. Differences in lipid levels, which were due to changes in determination methods and kits during study years, were corrected by using correction factor equations. Details about correction factor equations of lipid levels have been previously published. 15, 17 Altogether, 2443 individuals (1320 women, 1123 men) with blood DNA available have been genotyped with Illumina BeadChip Human670K array. The genotyped participants consist of approximately equal numbers of woman and men born in 1962, 1965, 1968, 1971, 1974, and 1977 . After baseline, missingness in the follow-ups was 15-25%, and women have participated slightly better. Description of participants and nonparticipants in the follow-ups can be found elsewhere. 15, 17 A directly genotyped SNP passing minor allele frequency Ͼ1%, genotype call rate and sample call rate Ͼ95%, and Hardy-Weinberg equilibrium (PϾ10 Ϫ5 ), was included in the study. We imputed SNPs not available in the genotype array with the HapMap 3 reference panel, using Utah residents with ancestry from Northern and Western Europe (CEU), Tuscans in Italy (TSI) 18 and Finnish reference sets 19 ; if not available in the HapMap 3 panel, the HapMap 2 panel was used., with CEU samples used as a reference. Imputation was performed with IMPUTE version 1.0.
We excluded nonfasted individuals (1.3%) and subjects taking statin medication for lipoprotein disorder (2.1%). Subjects gave written informed consent, and the study was approved by local ethics committees.
Selection of Genetic Markers
We chose each associated locus with genome-wide significance level of 5.0ϫ10
Ϫ8 in a recent meta-analysis of Ͼ100 000 individuals, 5 in total 47 for HDL-C, 37 for LDL-C, 52 for TC, and 32 for TG (see online-only Data Supplement Table 1 ). There were altogether 95 different associated loci; of those, 59 were reported for the first time. The genotypes were coded as 0, 1, or 2 when directly genotyped or as a predicted allele dosage (range, 0 -2) when imputed. We calculated a GRS for each lipid trait as a weighted sum of the effect alleles with the effect size of the SNP reported by Teslovich et al 5 as a weight and divided the sum by the number of the SNPs used. If genotyping had failed for an individual, the effect allele frequency of the study cohort was used in calculating the GRS as described elsewhere. 20 
Statistical Analysis
After the 3-year interval of the age of the study population, age was divided into 7 groups: 3-6, 9, 12, 15, 18, 21-30, and 33-45 years. Triglyceride measurements were transformed using natural logarithm. We applied a linear mixed-effects model to account for the correlation between intraindividual measurements in our longitudinal analysis for females and males separately. Models were estimated using the restricted maximum likelihood (REML) method with fixed covariates of age group and birth year and a random individual-specific and normally distributed intercept. If n denotes the number of individuals and m the number of age groups, the model for lipid phenotypes Y can be expressed as follows;
For each lipid trait, we evaluated if the effect of the GRS changed over age by testing if ␤ 4 ϭ0. Significance of the difference in GRS effects by age between sexes was tested by estimating the model jointly for women and men. The joint model (adjusted for sex, age group, and birth year) was estimated by maximum likelihood, and the likelihood ratio test was used to determine the significance of the interaction term between sex, age group, and GRS. For each lipid trait, the proportions of variance explained were calculated by linear model using the lipid-associated SNPs as predictors in each age and sex groups separately. Models were adjusted for age, and only the one measurement of each individual in each age group was used for estimation. Coefficients of determination were obtained as the difference in R 2 of the models with and without the genetic data.
To determine whether the GRS can improve adulthood dyslipidemia prediction, we used birth cohorts 1971, 1974 , and 1977 of the Young Finns in estimating logistic regression models for dyslipidemia of HDL-C, LDL-C, and TG (nϭ1204). These birth cohorts were chosen because they had lipid measurements at ages 9 and 30 -33 years. Dyslipidemia status was determined using thresholds for cases as HDL-C Ͻ1 mmol/L, LDL-C Ͼ3 mmol/L, and TG Ͼ2 mmol/L at 30 or 33 years old. [21] [22] [23] We evaluated how well the different lipid GRSs predicted lipid-specific dyslipidemias, in which an individual was defined as HDL, LDL, or TG dyslipidemia case if the criteria above were fulfilled. Additionally, we analyzed combined dyslipidemia status, in which an individual was defined as a case if any of the thresholds were exceeded. We compared the risk predictions of 2 models estimated for both sexes jointly: (1) age, birth year, sex, and a lipid measurement at 9 years old as predictors; and (2) in addition, the lipid related GRS as a predictor. To evaluate the improvement of the prediction ability when adding the genetic information into the model, we estimated model discrimination with the receiver operating characteristic (ROC) curves and calculated the change in the area under the ROC curve (AUC) between the models with and without the GRS. We tested the improvement of the prediction using the Venkatraman test for correlated ROC curves. 24 We additionally evaluated model discrimination with Integrated Discrimination Improvement (IDI) and relative IDI, which compares the mean difference in predicted probabilities between cases and noncases. Because of the potential limitations of AUC, 25 it has been proposed as an alternative discrimination measure. 26 The model calibration was tested with the Hosmer-Lemeshow test. 27 The R statistical package (version 2.12) was used for all analyses.
Results
Phenotype Characteristics
Average lipid levels by age and sex are shown in Figure 2 and Table 1 . There is considerable variation in lipid levels over age. In particular, HDL-C shows large decrease by age between 12 and 18 and between 21 and 36 years in males, after which they increase slightly over age. In females, HDL-C is less variable over age and reaches the top value at age 21 years. TG levels, however, show constant increase in males, especially between ages 10 and 30 years. In females, TG levels increase slightly after 20 years of age but remain relatively stable after 30 years. Variation between individuals is of the same magnitude in females and males, and it does not increase significantly by age, expect in TG.
Association of Individual SNPs With Lipid Levels
Overall 
Association of the GRS With Lipids
Genetic risk scores were highly associated with the particular lipid trait in all age and sex groups ( Figure 3 and online-only Data Supplement Table 6 ). There is a decreasing trend in the effect of the GRS on HDL-C and increasing on TG by age, whereas in the case of LDL-C and TC, the genetic effect is stable across age (Figure 3) . We saw an 
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age-GRS interaction effect in males on HDL-C (Pϭ0.02) and in both sexes on TG (Pϭ0.0001 in males, Pϭ0.009 in females). Figure 4 shows predicted lipid levels by highest and lowest 20% GRS group. The figure shows clear and consistent differences between high and low GRS group over age in LDL-C and TC. The difference between high and low GRS is slightly larger in children than adults in predicted HDL-C. On the contrary, the difference increases by age in TG levels, especially in males. The GRS effect profiles by age differ between sexes in TG (Pϭ0.02) (online-only Data Supplement Table 6 ). Adjusting the models for body mass index did not diminish the genetic effect (online-only Data Supplement Table 7) , which was not surprising because lipid GRSs are mostly independent on other metabolic and anthropometric traits (online-only Data Supplement Table 8 ).
Proportions of total variance of lipids explained by SNPs in adults (10 -12%) correspond to the estimates reported earlier 5 ( Table 2 ). Among the 3-to 6-year-old children, the known SNPs explained 26.7% of total variance of HDL-C in males, 21.9% in females, and around 10% in adults over 20 years. Proportions were similar in TC. In LDL-C, SNPs explained up to 19.5% in the youngest age group, and the proportion became slightly smaller over age. Proportion of TG variance explained by SNPs fluctuated between 7.4% and 14.8% and did not show similar decreasing trend. Adjusting the models for body mass index did not change the proportions notably (online-only Data Supplement Table 9 ).
GRSs as Predictors of Dyslipidemia in Adulthood
The proportions of dyslipidemia cases in the study sample according to the lipid-specific definitions among 30-to 33-year-olds (mean age, 31 years) were 17.3% (HDL dyslipidemia), 45.4% (LDL dyslipidemia), 12.7% (TG dyslipidemia), and 54.9% (combined dyslipidemia). When modeling the risk of lipid-specific dyslipidemias with and without GRSs, AUC estimates in the 2 models were (1) 0.82, 0.78, and 0.71 and (2) 0.81, 0.77, and 0.67 for HDL-C, LDL-C, and TG, respectively. Thus, AUC estimates increased by 0.01 (Pϭ0.14) for HDL-C, 0.005 (Pϭ0.54) for LDL-C, and 0.04 (Pϭ0.01) for TG ( Figure 5 ) when the GRS was added as a predictor. IDI was significant for all predictions of dyslipidemia when models with and without the GRS were compared; HDL-C indicates high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; and TG, triglycerides. ). The calibration of the models of dyslipidemias with and without genetic risk score was good (0.26ϽPϽ0.58 and 0.13ϽPϽ0.80, respectively). Lipid-specific GRSs did not improve risk crimination of combined dyslipidemia status over clinical lipid measurements. The gains in AUC estimates were small (0.0008 for HDL-C, 0.002 for LDL-C, and 0.001 for TG) and nonsignificant. IDI was significant only when LDL-GRS was added into the model (IDIϭ0.005; 95% CI, 0.000 -0.009; relative IDIϭ3%; Pϭ0.05).
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Discussion
Using a Finnish cohort with repeated measurements of lipid level between ages 3 and 45 years and genetic marker data, we have shown that lipid loci identified by previous GWA studies using adult samples were associated with lipid traits in all age groups between 3 and 45 years of age. Thus, the results from a large-scale screen for serum lipid loci in adult samples seem to generalize also to children in young ages and puberty. The effect of GRSs was similar across age groups for LDL-C and TC. The genetic effect in HDL-C levels was larger in children than in adults. Lipid loci explained a much larger part of the variance of HDL-C, LDL-C, and TC among younger than older age groups, which is in line with at least one study reporting higher heritability estimates for children than adults. 28 For TG, the effect of GRSs grew after 20 years as the average TG levels grew, and this difference was larger for males than females. However, this is not reflected as a larger proportion of variance explained by the SNPs in adult compared with children because the total variance of TG grows considerably after puberty. The results indicate that the proportion of environmental variance in lipid levels increases over age. This probably follows from the cumulative effect of lifestyle factors becoming more influential over age.
The TG-GRS improved hypertriglyceridemia risk discrimination in adults over childhood TG measurement when assessed by the C statistics comparing areas under ROC curves from the 2 models (AUC difference, 0.04; Pϭ0.01; Figure 5 ). However, the absolute AUC values were considerably lower in the prediction of hypertriglyceridemia than other dyslipidemias. This in turn also indicates that other risk factors (such as diet) and their interactions with genes are also important in the development of hypertriglyceridemia. Genetic risk scores did not improve the prediction of combined dyslipidemia status. LDL-GRS showed biggest difference (0.002) in the AUC in the combined dyslipidemia prediction, which is not surprising because most of the cases were identified through high LDL-C. As further lipid loci and causal variants are identified, the individual level estimates of genetic risk will become more consistent. The gained precision of genetic risk estimation in turn is likely to lead to more precise reclassifications of individuals, based on their overall risk, and lead to better identification of high-risk individuals for early interventions.
There may be several potential limitations in our study. First, our study was undertaken in individuals of Finnish descent and therefore the results may not be generalizable to others in Europe and other ancestries. Our study samples are from a prospectively followed longitudinal study, and there may be biases as the result of individuals lost to follow-up. The DNA was extracted from the 2001 and 2007 measurement wave, consisting of 63.5% of the original study partic- ipants. Second, we decided to use risk scores, that is, combinations of SNPs, to test for joint effects of SNPs in different age groups and to allow for prediction of hypercholesterolemia in adults. However, putting all SNPs into one score obscures some trends of associations of individual SNPs; whereas some SNPs in the GRSs have increasing effects, others have decreasing effects with age. For example, rs174601 (FADS1-2-3) shows significant associations with HDL-C only after 21 years of age, and rs12027135 (LDL-RAP1) is associated with LDL-C and TC only in adult age groups. On the contrary, some associations are specific for younger age groups (eg, PLTP loci in HDL-C and TG) (online-only Data Supplement Tables 2 through 5 ). Studying these effects in more detail could provide important information of genetic mechanisms influencing lipid levels during the life course. Finally, although based on SNP markers identified in the largest GWA study meta-analysis to date, our SNP panel might be incomplete for prediction.
In conclusion, we showed that 95 loci known to be associated with blood lipids in adults were also associated with lipids among children and adolescents. In total, the loci explained around 2 times more of HDL, LDL, and TC variation among young children than adults. For TG, the TG-GRS improved the risk prediction of adult hypertriglyceridemia over childhood lipid measurement, which suggests that genetic risk scores may provide useful additional information in initial assessment of an individual's risk for heart disease. However, further studies with more complete SNP panels and life course information are needed to evaluate the utility of the risk scores. 
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CLINICAL PERSPECTIVE
Recent genome-wide association studies have identified 95 single-nucleotide polymorphisms associated with blood lipid levels in adult populations. We studied these genetic variants both individually and as multilocus genetic risk scores (GRSs) and estimated their association with lipid levels of children and adolescents in Finnish Cardiovascular Risk in Young Finns Study. We observed that the lipid-specific GRSs were associated with lipids over the whole age span of the study (3-45 years). In total, the loci explained around 2 times more of high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and total cholesterol variation among young children than in adults. The GRSs improved the risk prediction of adult hypertriglyceridemia over childhood lipid measurements, which suggests that GRSs may potentially provide useful additional information in the initial assessment of an individual's risk for heart disease. Identifying children with high genetic risk for coronary heart disease could provide a reasonable classification of individuals who would benefit from systematic follow-up of their cholesterol levels, blood pressure, and other coronary heart disease risk factors. However, further studies with more complete single-nucleotide polymorphism panels and life course information are needed to evaluate the clinical utility of these GRSs.
